secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2024-05-30T23:59:59+00:00
Accession:  0001213900-24-047965
Event type: debt
Sentiment:  negative
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma extends convertible note maturity to Aug. 2025; minimum monthly payment cut 75%
--------------------------------------------------------------------------------

- Maturity date of $557,735 convertible note (Streeterville Capital) extended to August 19, 2025.
- Extension fee equal to 2% of outstanding balance added to principal; balance post-fee is $557,735.
- Minimum monthly redemption amount reduced from $150,000 to $37,182.33 per month.
- Original note principal was $5,250,000 issued November 2021; prior amendment in April 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390024047965/0001213900-24-047965-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390024047965/ea0207083-8k_china.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-047965

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer